Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years.
Michael J MackMartin B LeonVinod H ThouraniPhilippe PibarotRebecca T HahnPhilippe GenereuxSusheel K KodaliSamir R KapadiaDavid J CohenStuart J PocockMichael LuRoseann WhiteMolly SzerlipJulien TernacleS Chris MalaisrieHoward C HerrmannWilson Y SzetoMark J RussoVasilis BabaliarosCraig R SmithPhilipp BlankeJohn G WebbRaj Makkarnull nullPublished in: The New England journal of medicine (2023)
Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-group difference in the two primary composite outcomes. (Funded by Edwards Lifesciences; PARTNER 3 ClinicalTrials.gov number, NCT02675114.).
Keyphrases
- transcatheter aortic valve replacement
- aortic stenosis
- aortic valve
- aortic valve replacement
- transcatheter aortic valve implantation
- minimally invasive
- coronary artery bypass
- ejection fraction
- early onset
- left ventricular
- coronary artery disease
- surgical site infection
- adipose tissue
- type diabetes
- skeletal muscle
- insulin resistance
- atrial fibrillation
- acute coronary syndrome